China's Fosun Pharma to buy smaller stake in India's Gland Pharma for $1.1 billion: Reuters

Shanghai Fosun Pharmaceutical Group (600196.SS) is trimming the size of the stake it will buy in India’s Gland Pharma to 74 percent for $1.1 billion, in a bid to salvage the stalled deal that would be the biggest takeover by a Chinese firm in India, Reuters reported.

DealsNorth AmericaUSBriefs